A couple of other comments:
Striate: in first year did 20,000 units, exceeded expectations 1/4 on 1/4 growth 17%. Europe only recently stated marketing initial order of 1000 units. A couple of times stated - watch the quarterlies for growth.
Remplier: stated a couple of times will dominate the market, nothing anywhere near as good in the market. 90 surgeon's in Australia now using this product 900 units sold in first year.
ATI: still waiting for feedback but feeling was positive and the comment that it is competing with surgery which is an expensive option means ATI only needs to be as good and it will be taken up.
A couple of other comments:Striate: in first year did 20,000...
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $65.26K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56760 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.04pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |